Literature DB >> 23422071

Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid.

M Hollstein1, M Moriya2, A P Grollman2, M Olivier3.   

Abstract

Genetic alterations in cancer tissues may reflect the mutational fingerprint of environmental carcinogens. Here we review the pieces of evidence that support the role of aristolochic acid (AA) in inducing a mutational fingerprint in the tumor suppressor gene TP53 in urothelial carcinomas of the upper urinary tract (UUT). Exposure to AA, a nitrophenathrene carboxylic acid present in certain herbal remedies and in flour prepared from wheat grain contaminated with seeds of Aristolochia clematitis, has been linked to chronic nephropathy and UUT. TP53 mutations in UUT of individuals exposed to AA reveal a unique pattern of mutations characterized by A to T transversions on the non-transcribed strand, which cluster at hotspots rarely mutated in other cancers. This unusual pattern, originally discovered in UUTs from two different populations, one in Taiwan, and one in the Balkans, has been reproduced experimentally by treating mouse cells that harbor human TP53 sequences with AA. The convergence of molecular epidemiological and experimental data establishes a clear causal association between exposure to the human carcinogen AA and UUT. Despite bans on the sale of herbs containing AA, their use continues, raising global public health concern and an urgent need to identify populations at risk.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  7-(deoxyadenosin-N(6)-yl)aristolactam; AA; AA-UUT; AL-DNA adducts; AL-dA; Aristolochic acid(s); BEN; Balkan endemic nephropathy; COSMIC; Catalogue of Somatic Mutations in Cancer; HUF; Herbal remedies; Hotspot mutations; Hupki embryonic fibroblasts; IARC; IARC DB; IARC TP53 Database; ICGC; International Agency for Research on Cancer; International Cancer Genome Consortium; LOF; Nephropathy; TP53; TP53 mutation; Trp53; UUT; UUT tumors from patient cohorts with documented or suspected exposure to AA; UUT tumors from patient cohorts with no known or suspected exposure to AA; Urothelial cancer; aristolactam-DNA adducts; loss of wild-type function; nonAA-UUT; the human p53 tumor suppressor gene; the mouse p53 tumor suppressor gene; upper urinary tract tumors

Mesh:

Substances:

Year:  2013        PMID: 23422071      PMCID: PMC3689860          DOI: 10.1016/j.mrrev.2013.02.003

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  27 in total

Review 1.  DNA adducts: Formation, biological effects, and new biospecimens for mass spectrometric measurements in humans.

Authors:  Byeong Hwa Yun; Jingshu Guo; Medjda Bellamri; Robert J Turesky
Journal:  Mass Spectrom Rev       Date:  2018-06-11       Impact factor: 10.946

2.  Translesion synthesis of 6-nitrochrysene-derived 2'-deoxyadenosine adduct in human cells.

Authors:  Brent V Powell; Jan Henric T Bacurio; Ashis K Basu
Journal:  DNA Repair (Amst)       Date:  2020-07-18

Review 3.  Hypermutation in human cancer genomes: footprints and mechanisms.

Authors:  Steven A Roberts; Dmitry A Gordenin
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

4.  Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid.

Authors:  Bojan Jelaković; Xavier Castells; Karla Tomić; Maude Ardin; Sandra Karanović; Jiri Zavadil
Journal:  Int J Cancer       Date:  2014-12-10       Impact factor: 7.396

Review 5.  Why are there hotspot mutations in the TP53 gene in human cancers?

Authors:  Evan H Baugh; Hua Ke; Arnold J Levine; Richard A Bonneau; Chang S Chan
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

6.  Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid.

Authors:  Xavier Castells; Sandra Karanović; Maude Ardin; Karla Tomić; Evanguelos Xylinas; Geoffroy Durand; Stephanie Villar; Nathalie Forey; Florence Le Calvez-Kelm; Catherine Voegele; Krešimir Karlović; Maja Mišić; Damir Dittrich; Igor Dolgalev; James McKay; Shahrokh F Shariat; Viktoria S Sidorenko; Andrea Fernandes; Adriana Heguy; Kathleen G Dickman; Magali Olivier; Arthur P Grollman; Bojan Jelaković; Jiri Zavadil
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-09-17       Impact factor: 4.254

7.  A novel p53 mutant found in iatrogenic urothelial cancers is dysfunctional and can be rescued by a second-site global suppressor mutation.

Authors:  Adam F Odell; Luke R Odell; Jon M Askham; Hiba Alogheli; Sreenivasan Ponnambalam; Monica Hollstein
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

Review 8.  Somatic TP53 Mutations in the Era of Genome Sequencing.

Authors:  Pierre Hainaut; Gerd P Pfeifer
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

Review 9.  Genomic approaches to DNA repair and mutagenesis.

Authors:  John J Wyrick; Steven A Roberts
Journal:  DNA Repair (Amst)       Date:  2015-09-15

10.  Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.

Authors:  Margaret L Hoang; Chung-Hsin Chen; Viktoriya S Sidorenko; Jian He; Kathleen G Dickman; Byeong Hwa Yun; Masaaki Moriya; Noushin Niknafs; Christopher Douville; Rachel Karchin; Robert J Turesky; Yeong-Shiau Pu; Bert Vogelstein; Nickolas Papadopoulos; Arthur P Grollman; Kenneth W Kinzler; Thomas A Rosenquist
Journal:  Sci Transl Med       Date:  2013-08-07       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.